Literature DB >> 15121050

Recent advances in understanding serotonin regulation of cardiovascular function.

Francine Côté1, Cécile Fligny, Yves Fromes, Jacques Mallet, Guilan Vodjdani.   

Abstract

Serotonin is an important neurohormonal factor that has been implicated in cardiovascular function. It can regulate vascular tone, act directly on cardiomyocytes and stimulate chemosensitive nerves in the heart. Cardiovascular dysfunction is observed when serotonin signaling is altered or when variation in serotonin concentration occurs. Recent studies have provided evidence that, in the absence of peripheral serotonin synthesis, blood serotonin (which is almost exclusively stored in platelets) is markedly reduced, and that this drop leads to heart failure. This implies that the level of circulating serotonin is a key factor in maintaining normal cardiovascular activity. These findings offer new prospects for the use of serotonin in therapies for cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121050     DOI: 10.1016/j.molmed.2004.03.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  36 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

3.  Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.

Authors:  Andrew H Kemp; Tim Outhred; Sasha Saunders; Andre R Brunoni; Pradeep J Nathan; Gin S Malhi
Journal:  Psychopharmacology (Berl)       Date:  2013-12-15       Impact factor: 4.530

4.  Role of the serotonin transporter in heart valve development and disease.

Authors:  L M Pavone; A Spina; V Mastellone; R Lo Muto; E Fiorillo; L Avallone
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

5.  Empirically derived subtypes of serious emotional disturbance in a large adolescent sample.

Authors:  Nicholas Peiper; Richard Clayton; Richard Wilson; Robert Illback; Elizabeth O'Brien; Richard Kerber; Richard Baumgartner; Carlton Hornung
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-05       Impact factor: 4.328

Review 6.  5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.

Authors:  Stephanie W Watts; Robert Patrick Davis
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

7.  Evidence of sex differences in the relationship between current tobacco use and past-year serious psychological distress: 2005-2008 National Survey on Drug Use and Health.

Authors:  Nicholas Peiper; Brad Rodu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-28       Impact factor: 4.328

8.  Decreased contractile response of peripheral arterioles to serotonin after CPB in patients with diabetes.

Authors:  Sharif A Sabe; Jun Feng; Yuhong Liu; Laura A Scrimgeour; Afshin Ehsan; Frank W Sellke
Journal:  Surgery       Date:  2018-08       Impact factor: 3.982

9.  Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.

Authors:  Shane A Perrine; Mark S Michaels; Farhad Ghoddoussi; Elisabeth M Hyde; Manuel E Tancer; Matthew P Galloway
Journal:  NMR Biomed       Date:  2009-05       Impact factor: 4.044

10.  Peripheral serotoninergic response to physical exercise in athletic horses.

Authors:  Daniela Alberghina; Claudia Giannetto; Giuseppe Piccione
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.